药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Halazepam
Umeclidinium
The risk or severity of adverse effects can be increased when Escitalopram is combined with Umeclidinium.
Halazepam
Tiotropium
The risk or severity of adverse effects can be increased when Escitalopram is combined with Tiotropium.
Halazepam
Secretin porcine
The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Escitalopram.
Halazepam
Pramlintide
The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Escitalopram.
Halazepam
Mirabegron
The risk or severity of urinary retention can be increased when Escitalopram is combined with Mirabegron.
Halazepam
Aclidinium
The risk or severity of adverse effects can be increased when Escitalopram is combined with Aclidinium.
Halazepam
Dabrafenib
The serum concentration of Escitalopram can be decreased when it is combined with Dabrafenib.
Halazepam
Thalidomide
Escitalopram may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Halazepam
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Escitalopram.
Halazepam
Suvorexant
Escitalopram may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Halazepam
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Escitalopram.
Halazepam
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Escitalopram.
Halazepam
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Escitalopram.
Halazepam
Paraldehyde
Escitalopram may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Halazepam
Orphenadrine
Escitalopram may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Halazepam
Hydrocodone
Escitalopram may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Halazepam
Ioflupane I-123
Escitalopram may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.
Fenoldopam
Relugolix
The serum concentration of Relugolix can be decreased when it is combined with Phenobarbital.
Fenoldopam
Pralsetinib
The serum concentration of Phenobarbital can be decreased when it is combined with Pralsetinib.
Fenoldopam
Satralizumab
The serum concentration of Phenobarbital can be decreased when it is combined with Satralizumab.